Keros Therapeutics
KROS
KROS
163 hedge funds and large institutions have $2.03B invested in Keros Therapeutics in 2024 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 69 increasing their positions, 45 reducing their positions, and 15 closing their positions.
Holders
163
Holders Change
+11
Holders Change %
+7.24%
% of All Funds
2.36%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
26
Increased
69
Reduced
45
Closed
15
Calls
$4.47M
Puts
$528K
Net Calls
+$3.94M
Net Calls Change
+$2.28M
Top Buyers
Top Sellers
1 |
B
1
Braidwell
Stamford,
Connecticut
|
$41.1M |
2 |
O
2
OrbiMed
New York
|
$59.2M |
3 |
![]()
3
Adage Capital Partners
Boston,
Massachusetts
|
$0 |
4 |
4
Goldman Sachs
New York
|
$20.7M |
5 |
EAM
5
Eventide Asset Management
Boston,
Massachusetts
|
$22.1M |